Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The epidemiology of the Lambert-Eaton myasthenic syndrome in the Netherlands.
Wirtz PW, van Dijk JG, van Doorn PA, van Engelen BG, van der Kooi AJ, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Neurology. 2004 Jul 27;63(2):397-8. doi: 10.1212/01.wnl.0000130254.27019.14. Neurology. 2004. PMID: 15277653 No abstract available.
The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
Titulaer MJ, Wirtz PW, Kuks JB, Schelhaas HJ, van der Kooi AJ, Faber CG, van der Pol WL, de Visser M, Sillevis Smitt PA, Verschuuren JJ. Titulaer MJ, et al. Among authors: wirtz pw. J Neuroimmunol. 2008 Sep 15;201-202:153-8. doi: 10.1016/j.jneuroim.2008.05.025. Epub 2008 Jul 21. J Neuroimmunol. 2008. PMID: 18644631
Tonic pupils in Lambert-Eaton myasthenic syndrome.
Wirtz PW, de Keizer RJ, de Visser M, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Muscle Nerve. 2001 Mar;24(3):444-5. doi: 10.1002/1097-4598(200103)24:3<444::aid-mus1021>3.0.co;2-w. Muscle Nerve. 2001. PMID: 11353435 No abstract available.
Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.
Wirtz PW, Verschuuren JJ, van Dijk JG, de Kam ML, Schoemaker RC, van Hasselt JG, Titulaer MJ, Tjaden UR, den Hartigh J, van Gerven JM. Wirtz PW, et al. Clin Pharmacol Ther. 2009 Jul;86(1):44-8. doi: 10.1038/clpt.2009.35. Epub 2009 Apr 8. Clin Pharmacol Ther. 2009. PMID: 19357643 Clinical Trial.
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Among authors: wirtz pw. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC; IGOS consortium; GOS consortium. Verboon C, et al. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1080-1088. doi: 10.1136/jnnp-2020-325815. Epub 2021 Jun 8. J Neurol Neurosurg Psychiatry. 2021. PMID: 34103340 Free PMC article.
99 results